Long lasting neutralization of C5 by SKY59, a novel recycling antibody, is a potential therapy for complement-mediated diseases
Published 2017 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Long lasting neutralization of C5 by SKY59, a novel recycling antibody, is a potential therapy for complement-mediated diseases
Authors
Keywords
-
Journal
Scientific Reports
Volume 7, Issue 1, Pages -
Publisher
Springer Nature
Online
2017-04-18
DOI
10.1038/s41598-017-01087-7
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Identification of human IgG1 variant with enhanced FcRn binding and without increased binding to rheumatoid factor autoantibody
- (2017) Atsuhiko Maeda et al. mAbs
- Structural Basis for Eculizumab-Mediated Inhibition of the Complement Terminal Pathway
- (2016) Janus Asbjørn Schatz-Jakobsen et al. JOURNAL OF IMMUNOLOGY
- Unknown
- (2016) BRITISH JOURNAL OF HAEMATOLOGY
- Calcium-dependent antigen binding as a novel modality for antibody recycling by endosomal antigen dissociation
- (2015) N Hironiwa et al. mAbs
- Therapeutic drug monitoring of eculizumab: Rationale for an individualized dosing schedule
- (2015) Philippe Gatault et al. mAbs
- Age-related macular degeneration and the role of the complement system
- (2015) Selina McHarg et al. MOLECULAR IMMUNOLOGY
- Complement, a target for therapy in inflammatory and degenerative diseases
- (2015) B. Paul Morgan et al. NATURE REVIEWS DRUG DISCOVERY
- Complement System Part I – Molecular Mechanisms of Activation and Regulation
- (2015) Nicolas S. Merle et al. Frontiers in Immunology
- Complement and Its Receptors: New Insights into Human Disease
- (2014) V. Michael Holers Annual Review of Immunology
- Assessing complement blockade in patients with paroxysmal nocturnal hemoglobinuria receiving eculizumab
- (2014) R. Peffault de Latour et al. BLOOD
- Genetic Variants in C5 and Poor Response to Eculizumab
- (2014) Jun-ichi Nishimura et al. NEW ENGLAND JOURNAL OF MEDICINE
- Mechanistic Pharmacokinetic/Target Engagement/Pharmacodynamic (PK/TE/PD) Modeling in Deciphering Interplay Between a Monoclonal Antibody and Its Soluble Target in Cynomolgus Monkeys
- (2013) Weirong Wang et al. AAPS Journal
- How good are my data and what is the resolution?
- (2013) Philip R. Evans et al. ACTA CRYSTALLOGRAPHICA SECTION D-BIOLOGICAL CRYSTALLOGRAPHY
- A Novel Investigational Fc-Modified Humanized Monoclonal Antibody, Motavizumab-YTE, Has an Extended Half-Life in Healthy Adults
- (2013) Gabriel J. Robbie et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Identification and Multidimensional Optimization of an Asymmetric Bispecific IgG Antibody Mimicking the Function of Factor VIII Cofactor Activity
- (2013) Zenjiro Sampei et al. PLoS One
- Monoclonal antibody therapeutics: history and future
- (2012) Nicholas APS Buss et al. CURRENT OPINION IN PHARMACOLOGY
- C3 glomerulonephritis: clinicopathological findings, complement abnormalities, glomerular proteomic profile, treatment, and follow-up
- (2012) Sanjeev Sethi et al. KIDNEY INTERNATIONAL
- Use of eculizumab for atypical haemolytic uraemic syndrome and C3 glomerulopathies
- (2012) Julien Zuber et al. Nature Reviews Nephrology
- REFMAC5 for the refinement of macromolecular crystal structures
- (2011) Garib N. Murshudov et al. ACTA CRYSTALLOGRAPHICA SECTION D-BIOLOGICAL CRYSTALLOGRAPHY
- Eculizumab
- (2011) Kate McKeage DRUGS
- Therapeutic antibodies: Market considerations, disease targets and bioprocessing
- (2011) John G. Elvin et al. INTERNATIONAL JOURNAL OF PHARMACEUTICS
- XDS
- (2010) Wolfgang Kabsch ACTA CRYSTALLOGRAPHICA SECTION D-BIOLOGICAL CRYSTALLOGRAPHY
- Features and development ofCoot
- (2010) P. Emsley et al. ACTA CRYSTALLOGRAPHICA SECTION D-BIOLOGICAL CRYSTALLOGRAPHY
- Structure of the Complex between HER2 and an Antibody Paratope Formed by Side Chains from Tryptophan and Serine
- (2010) Robert D. Fisher et al. JOURNAL OF MOLECULAR BIOLOGY
- Properties of a general PK/PD model of antibody-ligand interactions for therapeutic antibodies that bind to soluble endogenous targets
- (2010) Jasmine P. Davda et al. mAbs
- Antibody recycling by engineered pH-dependent antigen binding improves the duration of antigen neutralization
- (2010) Tomoyuki Igawa et al. NATURE BIOTECHNOLOGY
- Enhanced antibody half-life improves in vivo activity
- (2010) Jonathan Zalevsky et al. NATURE BIOTECHNOLOGY
- Molecular mechanisms of complement evasion: learning from staphylococci and meningococci
- (2010) Davide Serruto et al. NATURE REVIEWS MICROBIOLOGY
- xia2: an expert system for macromolecular crystallography data reduction
- (2009) G. Winter JOURNAL OF APPLIED CRYSTALLOGRAPHY
- Atypical Hemolytic–Uremic Syndrome
- (2009) Marina Noris et al. NEW ENGLAND JOURNAL OF MEDICINE
- Structure of and influence of a tick complement inhibitor on human complement component 5
- (2008) Folmer Fredslund et al. NATURE IMMUNOLOGY
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started